128 related articles for article (PubMed ID: 2133093)
1. Studies on the cytochrome P-450 catalyzed ring alpha-carbon oxidation of the nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Ottoboni S; Carlson TJ; Trager WF; Castagnoli K; Castagnoli N
Chem Res Toxicol; 1990; 3(5):423-7. PubMed ID: 2133093
[TBL] [Abstract][Full Text] [Related]
2. Deuterium isotope effects for the oxidation of 1-methyl-3-phenyl-3-pyrrolinyl analogues by monoamine oxidase B.
Pretorius A; Ogunrombi MO; Terre'blanche G; Castagnoli N; Bergh JJ; Petzer JP
Bioorg Med Chem; 2008 Oct; 16(19):8813-7. PubMed ID: 18799315
[TBL] [Abstract][Full Text] [Related]
3. Metabolic studies on the nigrostriatal toxin MPTP and its MAO B generated dihydropyridinium metabolite MPDP+.
Wu E; Shinka T; Caldera-Munoz P; Yoshizumi H; Trevor A; Castagnoli N
Chem Res Toxicol; 1988; 1(3):186-94. PubMed ID: 2979730
[TBL] [Abstract][Full Text] [Related]
4. Studies on the 1-methyl-4-phenyl-2,3-dihydropyridinium species 2,3-MPDP+, the monoamine oxidase catalyzed oxidation product of the nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Peterson LA; Caldera PS; Trevor A; Chiba K; Castagnoli N
J Med Chem; 1985 Oct; 28(10):1432-6. PubMed ID: 3876442
[TBL] [Abstract][Full Text] [Related]
5. Deuterium isotope effect measurements on the interactions of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine with monoamine oxidase B.
Ottoboni S; Caldera P; Trevor A; Castagnoli N
J Biol Chem; 1989 Aug; 264(23):13684-8. PubMed ID: 2788162
[TBL] [Abstract][Full Text] [Related]
6. 1-Methyl-4-phenyl-2,3-dihydropyridinium is transformed by ubiquinone to the selective nigrostriatal toxin 1-methyl-4-phenylpyridinium.
Shi H; Noguchi N; Xu Y; Niki E
FEBS Lett; 1999 Nov; 461(3):196-200. PubMed ID: 10567696
[TBL] [Abstract][Full Text] [Related]
7. Reversible inhibition and mechanism-based irreversible inactivation of monoamine oxidases by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Singer TP; Salach JI; Crabtree D
Biochem Biophys Res Commun; 1985 Mar; 127(2):707-12. PubMed ID: 3872126
[TBL] [Abstract][Full Text] [Related]
8. Nitroindazole compounds inhibit the oxidative activation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxin to neurotoxic pyridinium cations by human monoamine oxidase (MAO).
Herraiz T; Arán VJ; Guillén H
Free Radic Res; 2009 Oct; 43(10):975-84. PubMed ID: 19669997
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the oxidation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to toxic pyridinium cations by monoamine oxidase (MAO) enzymes and its use to search for new MAO inhibitors and protective agents.
Herraiz T
J Enzyme Inhib Med Chem; 2012 Dec; 27(6):810-7. PubMed ID: 21992679
[TBL] [Abstract][Full Text] [Related]
10. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine- and 1-methyl-4-(2'-ethylphenyl)-1,2,3,6-tetrahydropyridine-induced toxicity in PC12 cells: role of monoamine oxidase A.
Basma AN; Heikkila RE; Nicklas WJ; Giovanni A; Geller HM
J Neurochem; 1990 Sep; 55(3):870-7. PubMed ID: 2384758
[TBL] [Abstract][Full Text] [Related]
11. The formation of reactive intermediates in the MAO-catalyzed oxidation of the nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Trevor AJ; Castagnoli N; Singer TP
Toxicology; 1988 May; 49(2-3):513-9. PubMed ID: 3287698
[TBL] [Abstract][Full Text] [Related]
12. Potential bioactivation pathways for the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Castagnoli N; Chiba K; Trevor AJ
Life Sci; 1985 Jan; 36(3):225-30. PubMed ID: 3871243
[TBL] [Abstract][Full Text] [Related]
13. Interactions of the neurotoxic amine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine with monoamine oxidases.
Singer TP; Salach JI; Castagnoli N; Trevor A
Biochem J; 1986 May; 235(3):785-9. PubMed ID: 3489461
[TBL] [Abstract][Full Text] [Related]
14. Processing of MPTP by monoamine oxidases: implications for molecular toxicology.
Trevor AJ; Singer TP; Ramsay RR; Castagnoli N
J Neural Transm Suppl; 1987; 23():73-89. PubMed ID: 3295117
[TBL] [Abstract][Full Text] [Related]
15. Activation and deactivation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by cytochrome P450 enzymes and flavin-containing monooxygenases in common marmosets (Callithrix jacchus).
Uehara S; Uno Y; Inoue T; Murayama N; Shimizu M; Sasaki E; Yamazaki H
Drug Metab Dispos; 2015 May; 43(5):735-42. PubMed ID: 25735838
[TBL] [Abstract][Full Text] [Related]
16. Biotransformation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in primary cultures of mouse astrocytes.
Di Monte DA; Wu EY; Irwin I; Delanney LE; Langston JW
J Pharmacol Exp Ther; 1991 Aug; 258(2):594-600. PubMed ID: 1907660
[TBL] [Abstract][Full Text] [Related]
17. Preferential Extracellular Generation of the Active Parkinsonian Toxin MPP+ by Transporter-Independent Export of the Intermediate MPDP+.
Schildknecht S; Pape R; Meiser J; Karreman C; Strittmatter T; Odermatt M; Cirri E; Friemel A; Ringwald M; Pasquarelli N; Ferger B; Brunner T; Marx A; Möller HM; Hiller K; Leist M
Antioxid Redox Signal; 2015 Nov; 23(13):1001-16. PubMed ID: 26413876
[TBL] [Abstract][Full Text] [Related]
18. Studies on 4-benzyl-1-methyl-1,2,3,6-tetrahydropyridine, a nonneurotoxic analogue of the parkinsonian inducing agent 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Naiman N; Rollema H; Johnson E; Castagnoli N
Chem Res Toxicol; 1990; 3(2):133-8. PubMed ID: 2130940
[TBL] [Abstract][Full Text] [Related]
19. Cytochrome P4502D and -2C enzymes catalyze the oxidative N-demethylation of the parkinsonism-inducing substance 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in rat liver microsomes.
Narimatsu S; Tachibana M; Masubuchi Y; Suzuki T
Chem Res Toxicol; 1996; 9(1):93-8. PubMed ID: 8924622
[TBL] [Abstract][Full Text] [Related]
20. Metabolite profile resulting from the activation/inactivation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 2-methyltetrahydro-β-carboline by oxidative enzymes.
Herraiz T; Guillén H; Galisteo J
Biomed Res Int; 2013; 2013():248608. PubMed ID: 23984327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]